873 related articles for article (PubMed ID: 8803910)
21. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
[TBL] [Abstract][Full Text] [Related]
22. Adverse events in methotrexate-treated rheumatoid arthritis patients.
Sandoval DM; Alarcón GS; Morgan SL
Br J Rheumatol; 1995 Nov; 34 Suppl 2():49-56. PubMed ID: 8535650
[TBL] [Abstract][Full Text] [Related]
23. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
[TBL] [Abstract][Full Text] [Related]
25. [Methotrexate combined with leflunomide or hydroxychloroquine in the treatment of rheumatoid arteritis].
Zhang X; Cui Y; Luo rQ; Yao RY; Zhou H
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1038-40. PubMed ID: 15312543
[No Abstract] [Full Text] [Related]
26. Pharmacogenomics in rheumatoid arthritis.
Ranganathan P
Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
[TBL] [Abstract][Full Text] [Related]
27. [Combination therapy of disease-modifying antirheumatic drugs(DMARDs) in rheumatoid arthritis].
Kobayashi S; Kanai Y
Nihon Rinsho; 2002 Dec; 60(12):2351-6. PubMed ID: 12510361
[TBL] [Abstract][Full Text] [Related]
28. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
29. [Combination therapy in rheumatoid arthritis].
Johnsen V; Førre Ø; Haga HJ; Kvien TK; Mikkelsen K; Nordvåg BY; Rødevand E
Tidsskr Nor Laegeforen; 2003 May; 123(11):1511-3. PubMed ID: 12822010
[TBL] [Abstract][Full Text] [Related]
30. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.
Nash P; Clegg DO
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii74-7. PubMed ID: 15708943
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.
Kapral T; Stamm T; Machold KP; Montag K; Smolen JS; Aletaha D
Arthritis Res Ther; 2006; 8(2):R46. PubMed ID: 16507172
[TBL] [Abstract][Full Text] [Related]
32. [Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil].
Sergiets NA; Erov NK
Ter Arkh; 2009; 81(6):34-7. PubMed ID: 19663190
[TBL] [Abstract][Full Text] [Related]
33. Prescription rheumatology practices among Mexican specialists.
Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
[TBL] [Abstract][Full Text] [Related]
34. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
van Jaarsveld CH; Jahangier ZN; Jacobs JW; Blaauw AA; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Schenk Y; van Der Veen MJ; Bijlsma JW
Rheumatology (Oxford); 2000 Dec; 39(12):1374-82. PubMed ID: 11136881
[TBL] [Abstract][Full Text] [Related]
35. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
[TBL] [Abstract][Full Text] [Related]
36. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
[TBL] [Abstract][Full Text] [Related]
37. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
[TBL] [Abstract][Full Text] [Related]
38. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
Ranganath VK; Furst DE
Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
[TBL] [Abstract][Full Text] [Related]
39. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
Conaghan PG; Brooks P
Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
[TBL] [Abstract][Full Text] [Related]
40. [Use of NSAIDs in rheumatoid arthritis should be limited].
Lindberg M
Ugeskr Laeger; 2013 Apr; 175(15):1039-41. PubMed ID: 23582126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]